Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
46.65
-2.37 (-4.83%)
At close: Sep 18, 2026, 4:00 PM EDT
47.00
+0.35 (0.75%)
After-hours: Sep 18, 2026, 7:49 PM EDT
Scholar Rock Holding Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
289
Market Cap
5.68B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 33.19M | 14.38M | 76.41% |
| Dec 31, 2021 | 18.82M | 3.41M | 22.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PTC Therapeutics | 1.01B |
| Mirum Pharmaceuticals | 618.07M |
| Travere Therapeutics | 591.33M |
| Ligand Pharmaceuticals | 290.54M |
| Rhythm Pharmaceuticals | 239.92M |
| Xenon Pharmaceuticals | 7.50M |
| CG Oncology | 6.23M |
| Dianthus Therapeutics | 1.90M |
SRRK News
- 4 days ago - Scholar Rock says FDA requested pregnancy safety study for Isembyld - TheFly
- 4 days ago - Scholar Rock Stock (SRRK) Slides Over 7% on an FDA Safety Update - TipRanks
- 4 days ago - Scholar Rock price target raised to $72 from $65 at Evercore ISI - TheFly
- 4 days ago - Scholar Rock price target raised to $70 from $64 at Wedbush - TheFly
- 4 days ago - Scholar Rock price target raised to $75 from $60 at Piper Sandler - TheFly
- 4 days ago - Scholar Rock price target raised to $70 from $65 at H.C. Wainwright - TheFly
- 4 days ago - Barclays downgrades Scholar Rock on valuation after FDA approval - TheFly
- 4 days ago - Scholar Rock downgraded to Equal Weight from Overweight at Barclays - TheFly